Company behind GcMaf is declared insolvent
IMMUNO BIOTECH, the company behind ‘wonder drug’ GcMaf, has been declared insolvent as efforts progress towards recovering a total of more than £300,000 owed to the Income Tax Department.
Three judgments in favour of Income Tax were made against the company at the end of 2016 in the amounts of £83,121.91, £107,327.17 and £110,000 – a total of £300,449.08.
As well as declaring the company insolvent, or en desastre, the Royal Court also recently confirmed an order that a quantity of gold and silver bullion seized should be sold off.
Jurat Jonathan Tooley has now been appointed commissioner for the marshalling of the debt.
At a brief preliminary hearing this week, Jurat Tooley was informed by HM Sheriff Jayne Limond that the bullion had been sold for its market value.
As well as the three Royal Court judgment debts against Immuno Biotech there was a further claim of £10,500 as the result of an award made by an employment tribunal brought against the firm by a former employee.
There was also a Petty Debts Court judgment in favour of Income Tax to the value of £8,293.06.
Mrs Limond said that the current status was that a total of £47,762.73 had been arrested to date. For the States, Crown Advocate Robin Gist said that he had no difficulty foregoing the Petty Debt judgment and would proceed on the basis of the three Royal Court judgments.
Jurat Tooley said the next stage was to assess which of the claims against the company were preferred debts and which were secured, and Advocate Gist said that he would prepare a list to identify the preferred debts for a future hearing. Jurat Tooley added that the Sheriff’s and creditors’ costs would also need to be identified.
Immuno Biotech was not represented at the preliminary hearing.
